Heparin-induced thrombocytopenia (hit) occurs in 5% to 15% of all individuals who receive heparin therapy. in these individuals, the administration of heparin induces platelet aggregation and thrombus formation. the antibody-mediated destruction of platelets. lysis of megakaryocytes in the bone marrow. the release of deformed platelets that are unable to form clots.